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Ageing is associated with loss of skeletal muscle ﬁbres, atrophy of the remaining ﬁbres and weakness.
These changes in muscle are accompanied by disruption of motor neurons and neuromuscular junctions
although the direct relationship between the nerve and muscle degeneration is not understood. Oxi-
dative changes have been implicated in the mechanisms leading to age-related loss of muscle mass and
in degeneration of the central nervous system, but little is known about age-related changes in oxidation
in speciﬁc peripheral nerves that supply muscles that are affected by ageing. We have therefore ex-
amined the sciatic nerve of old mice at an age when loss of tibialis anterior muscle mass and function is
apparent. Sciatic nerve from old mice did not show a gross increase in oxidative damage, but electron
paramagnetic resonance (EPR) studies indicated an increase in the activity of superoxide and/or per-
oxynitrite in the nerves of old mice at rest that was further exacerbated by electrical stimulation of the
nerve to activate muscle contractions. Proteomic analyses indicated that speciﬁc redox-sensitive proteins
are increased in content in the nerves of old mice that may reﬂect an adaptation to regulate the increased
superoxide/peroxynitrite and maintain redox homoeostasis. Analysis of redox active cysteines showed
some increase in reversible oxidation in speciﬁc proteins in nerves of old mice, but this was not uni-
versally seen across all redox-active cysteines. Detailed analysis of the redox-active cysteine in one
protein in the nerve of old mice that is key to redox signalling (Peroxiredoxin 6, Cys 47) showed a minor
increase in reversible oxidation that would be compatible with a change in its redox signalling function.
In conclusion, the data presented indicate that sciatic nerve from old mice does not show a gross increase
in oxidative damage similar to that seen in the TA and other muscles that it innervates. Our results
indicate an adaptation to increased oxidation with minor changes in the oxidation of key cysteines that
may contribute to defective redox signalling in the nerve.
& 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Age-related loss of muscle ﬁbres occurs over a substantial
portion of later life and plays a major role in declining quality of
life in older people [1]. Cross-sectional data from Lexell et al. [2,3]
indicate that the number of skeletal muscle ﬁbres decreased in
man from 50 years of age and continue to decrease over sub-
sequent years. Similar rates of loss of motor units are observed in
EMG studies in ageing [4]. There is good evidence of denervationr Inc. This is an open access article
roxy-3-carboxy-2,2,5,5-tetra-
nnel isoform; NCAM, Neural
J, Neuromuscular junction;
, CuZn superoxide dismutase
ackson).in muscle ﬁbres from elderly subjects with ﬁbre type grouping,
accumulation of severely atrophic angular ﬁbres, and expression of
proteins associated with denervation such as neural cell adhesion
molecule (NCAM) and the voltage gated sodium channel isoform
(Nav1.5) by the atrophic ﬁbres [5–10]. There is also evidence that
in both man and rodents, a reduction in the number of motor
neurons occurs with ageing [10,11]. The role of this change in in-
nervation in age-related loss of muscle ﬁbres is unknown, al-
though denervation can lead to loss of muscle ﬁbres and con-
versely experimental damage to muscle can lead to loss of the
innervating neuromuscular junction (NMJ) (e.g. see [12,13]).
Studies of the innervation of individual muscle ﬁbres in aged
mice have observed NMJs with a variety of age-related structural
alterations, including axonal swellings, sprouting, synaptic de-
tachment, partial or complete withdrawal of axons from some
postsynaptic sites, and fragmentation of the postsynaptic specia-
lization [14,15]. Some recent data from rodents also indicate thatunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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with aging, the number of motor neuron cell bodies in the lumbar
spinal cord is relatively spared suggesting that changes pre-
dominantly occur in the periphery of motor units [14].
Although recent data indicate that reactive oxygen species
(ROS)-induced oxidative damage is not the fundamental cause of
ageing (or more precisely, the fundamental determinant of life-
span) [16,17], tissues of all aged organisms are reported to contain
increased oxidative damage to lipids, DNA and proteins [18–20].
Many studies have reported that mitochondrial ROS generation is
increased during ageing [21] and this occurs in association with
impaired mitochondrial function, oxidative damage and a change
in mitochondrial redox potential [22,23].
A mechanistic link between chronic oxidative stress in vivo and
a loss of muscle mass and force is supported by studies of mice
deﬁcient in CuZn-superoxide dismutase (SOD1) (Sod1 / mice), a
major antioxidant enzyme. Skeletal muscles from young Sod1 /
mice display elevated oxidative damage to proteins, lipids, and
DNA compared with those of age-matched wild-type (WT) mice
and muscle masses are signiﬁcantly lower than those of WT mice
as early as 6 months of age [12]. Muscle mass in the Sod1 / mice
is further reduced with age, and, by 20 months, hindlimb muscle
mass in Sod1/ mice is nearly 50% lower than that in age-mat-
ched WT mice [12]. Furthermore, we have shown that restoration
of CuZnSOD only in neurons of Sod1KO mice prevented the in-
creased muscle mitochondrial ROS production, premature muscle
atrophy, and weakness [24] suggesting that altered redox status in
the motor neuron is likely an initiating event responsible for the
neuromuscular declines observed early in life in Sod1KO mice and
potentially during normal aging.
A number of studies have examined the effect of age on oxi-
dative stress and redox regulation in the central nervous system
e.g. [25,26], but data on the redox status of the peripheral nervous
system during ageing is sparse. In the light of the evidence that
changes in redox homoeostasis in motor neurons may occur in the
periphery of motor units, the aim of the current work was to use
novel experimental approaches to examine the redox homo-
eostasis of peripheral nerves of wild type mice at the age when
loss of muscle ﬁbres and weakness occurs. We hypothesised that
the sciatic nerve of mice would show age-related changes in the
activities of speciﬁc reactive oxygen species and redox homo-
eostasis that may contribute to loss of neuron function and loss of
muscle innervation.2. Methods
2.1. Mice
Adult (6–8 months) and old (26–28 months) male WT C57Bl6
mice and adult mice were fed on a standard laboratory diet and
subjected to a 12-h light/dark cycle. Experiments were performed
in accordance with UK Home Ofﬁce guidelines under the UK An-
imals (Scientiﬁc Procedures) Act 1986 and received ethical ap-
proval from the University of Liverpool Animal Welfare Commit-
tee. The aesthetic used varied depending up on the experimental
design. Mice were anesthetized with pentobarbital sodium, with
an initial dose of 65 mg/kg body mass for adult mice and 20 mg/kg
for old mice via an intraperitoneal injection, supplemental doses
were administered as required to maintain a depth of anaesthesia
sufﬁcient to prevent response to tactile stimuli. In other experi-
ments old and adult mice were anesthetised using gas anaesthesia,
in 2% isoﬂurane in 2 l/min oxygen delivered via a precision
vaporizer.2.2. In vivo contraction protocol
Each age cohort was split into three equal groups: (i) control
mice, which did not receive the contraction protocol (un-
stimulated); (ii) mice that received the contraction protocol and an
infusion of 1-Hydroxy-3-carboxy-2,2,5,5-tetramethylpyrrolidine
(CPH) was started immediately following the end of the contrac-
tions, mice were sacriﬁced at 2 h post contractions; and (iii) mice
that received the contraction protocol and allowed to recover for
24 h before commencing the 2 h CPH infusion. For the mice in
groups ii and iii, both hindlimbs were subjected to a 15-min period
of nerve stimulation to generate isometric contractions of the
hindlimb muscles [27]. The stimulation protocol used was a square
wave pulse of 0.2 ms duration at 60 V and a frequency of 100 Hz
contracted every 4 s and repeated 180 times. Pentobarbital sodium
was used as the anaesthetic throughout and mice were sacriﬁced
by administration of an overdose of anaesthetic at the times de-
scribed above and the sciatic nerves were immediately dissected.
2.3. Sciatic nerve dissection and analysis
The nerve was followed distally towards the tibial and common
ﬁbular nerve branches. The nerve was then followed proximally,
using the scissors to break through the sciatic notch, tracing the
nerve back to its ﬁve vertebral roots (L4-S3). The sciatic nerve was
then dissected at the post-vertebral level and at a random point
pre-branching of the tibial and common ﬁbular branches, re-
moving minor branches and connective tissue along the nerve.
For structural examination, sciatic nerves from 7 mice at each
age were left overnight in a solution of 4% PFA and 2% glutar-
aldehyde. The following day the nerves were washed twice with
PBS and tissues were incubated for 3 h at room temperature in 1%
osmium tetroxide (OsO4) and 0.1 M PBS. Extensive washing with
distilled water was followed by an overnight incubation in 1%
uranyl acetate at room temperature. The next day tissues were
dehydrated in ethanol for 5 min and subsequently washed in
ethanol. Post-dehydration, tissues underwent a series of resin in-
ﬁltration: 10% for 1 h, 50% resin for 2 h, 75% resin for 1 h, 100%
resin for 1 h, ending by embedding in fresh 100% resin cured in a
60 °C oven for 72 h.
The resin-embedded nerve was cut using Leica EM UC6 Mi-
crotome to create a protruding square approximately
350350 mm2 by use of a glass blade. Semi-thin sections were
then obtained using a diamond blade, immersed in water and
mounted on a microscope slide. A Ziess Axio Imager M1 was used
to take randomised 100100 mm2 images of sections following
staining with 1% toluidine blue. Images were analysed using image
analysis software (AxioVision LE). Markings of length and area
were manually created, with subsequent calculation of values by
the AxioVision LE software.
2.4. In vivo electron paramagnetic resonance analysis of the sciatic
nerve
In order to deﬁne the activities of speciﬁc ROS (superoxide and/
or peroxynitrite) in the sciatic nerve prior to, and following con-
tractile activity, an in vivo electron paramagnetic resonance (EPR)
spin probe approach was used [28]. Anesthetised mice (n¼7 for
each age and time point) were given an intravenous infusion of
1-Hydroxy-3-carboxy-2,2,5,5-tetramethylpyrrolidine (CPH; 9 mg/
kg body weight bolus followed by 0.225 mg/kg/min over 2 h) via
the tail vein and after 2 h the mice were killed and the sciatic
nerve rapidly dissected and stored under liquid nitrogen until
analysis. Samples were examined under liquid nitrogen and the
stable 3-carboxy-proxyl radical formed by reaction of CPH with
superoxide or peroxynitrite determined by EPR (Bruker e-scan
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perature measurements were: microwave frequency 9.78 GHz,
modulation frequency 86 kHz, modulation amplitude 6.15 G, gain
103. Upon oxidation CPH is converted to the stable CP radical (3-
carboxy-proxyl), standard solutions of CP were used to relatively
quantify superoxide/peroxynitrite generated in the sciatic nerve [28].
2.5. Proteomic analyses of sciatic nerve
Sciatic nerve samples from adult (n¼4) and old (n¼4) mice
were prepared for proteomic analysis and quantiﬁcation using a
label-free quantitative proteomic approach that includes a differ-
ential cysteine labelling step as recently described [29]. The ap-
proach allows simultaneous identiﬁcation of up- and down regu-
lated proteins between samples using global label free proteomics.
In addition a targeted analysis of redox sensitive cysteine residues
allows the identiﬁcation and relative quantiﬁcation of the re-
versible oxidation state of susceptible redox cysteine residues
within samples. The proteomics analysis was performed as pre-
viously described [30]. The data-dependent label-free analysis was
performed using an Ultimate 3000 RSLC™ nano system (Thermo
Scientiﬁc, Hemel Hempstead, UK) coupled to a QExactive™ mass
spectrometer (Thermo Scientiﬁc). The sample (5 mL corresponding
to 250 ng of protein) was loaded onto the trapping column
(Thermo Scientiﬁc, PepMap100, C18, 75 μm20 mm), using par-
tial loop injection, for 7 min at a ﬂow rate of 4 μL/min with 0.1%
(v/v) TFA. The sample was resolved on the analytical column
(Easy-Spray C18 75 mm500 mm2 mm column) using a gra-
dient of 97% A (0.1% formic acid) 3% B (99.9% ACN 0. 1% formic acid)
to 60% A 40% B over 120 min at a ﬂow rate of 300 nL/min. The
programme used for data acquisition consisted of a 70,000 re-
solution full-scan MS scan (AGC set to 106 ions with a maximum
ﬁll time of 250 ms) the 10 most abundant peaks were selected for
MS/MS using a 17,000 resolution scan (AGC set to 5104 ions with
a maximum ﬁll time of 250 ms) with an ion selection window of
3 m/z and a normalized collision energy of 30. To avoid repeated
selection of peptides for MS/MS the programme used a 30 s dy-
namic exclusion window.
Raw spectra were converted to mascot generated ﬁles (.mgf)
using Proteome Discoverer software (Thermo Scientiﬁc). The re-
sulting mgf ﬁles were searched against the Uniprot Mouse data-
base sequence database (12/05/2012, 16376 sequences) using an
in-house Mascot server (Matrix Science, London, UK). Search
parameters used were: peptide mass tolerances, 10 ppm; fragment
mass tolerance, 0.01 Da, 1þ , 2þ and 3þ ions; missed cleavages, 1;
instrument type, ESI-TRAP. Variable modiﬁcations included were:
d(0) N-ethylmaleimide (NEM), d(5) NEM, mono-, di- and tri-oxi-
dation of cysteine residues and oxidation of methionine and a false
discovery rate ofo1%. Label-free relative quantiﬁcation software
PEAKS™ 7 (Bioinformatics Solutions Inc, Waterloo Canada) was
used to analyse RAW data ﬁles against the same mouse protein
database for identiﬁcations with Mascot [31]. Proteins were con-
sidered signiﬁcantly changed between adult and aged samples
using a 10log P score420 (equivalent to a P valueo0.01) and
using a quality value of 40.5. The full list of identiﬁed proteins
including statistical analysis of protein and peptide features is
included in Supplementary Files 1 and 2. Cysteine containing
peptides detected with identical amino acid sequences, and both d
(0) and d(5) NEM modiﬁcations independently with an individual
peptide ion Mascot score of420 were considered redox peptides.
Redox peptides detected from Proteome Discovery analyses of
RAW ﬁles were selected for targeted analysis using m/z data and
retention times with the open software Skyline™ [32]. Targeted
analysis applying m/z, retention times and fragmentation spectra
for peptide selection allowed the estimation of the reduced:oxi-
dized ratio (or d(0) / d(5) NEM) of the Cys residues using theindividual parent ion intensities with Skyline™. The individual
reduced:oxidized ratio for redox Cys peptides in each sample was
used to calculate an average ratio of reduced:oxidized calculated
for the speciﬁc cysteine residues. Intensities of targeted peptides
are included in Supplementary File 3.
2.6. Western blotting for the protein carbonyl and peroxiredoxin
5 and 6 content of sciatic nerve
Western blotting techniques were used to assess the protein
carbonyl and peroxiredoxin (Prdx) 5 and 6 contents of sciatic nerve
(n¼4) following homogenisation as previously described [24].
2.7. Statistical analyses for structural analysis and blotting
Data are presented as means7SEM for each experiment.
Comparisons were performed by 1-way ANOVA followed by the
post hoc LSD test. Values of Po0.05 were considered statistically
signiﬁcant.3. Results
In previous studies examining the effect of ageing in C57Bl6
mice, we have shown a reduced mass of the hind limb muscles,
such as the tibialis anterior (TA) muscle at 2628 months of age
(e.g. see [33]) and examination of the morphological structure of
the sciatic nerve that innervates these muscles showed that,
compared with adult mice, those at 2628 months had disruption
of the normal axonal structure. Example semi-thin transverse
sections are shown in Fig. 1. Analysis of the cross sections from
mice at both ages revealed a decrease in the mean diameter of
axons, a decrease in the number of axons present within each ﬁeld
and a reduced myelination of axons (Table 1).
In order to study the reactive species present in sciatic nerves
of adult and old mice, an EPR and spin probe approach was used.
The data shown in Fig. 2A and B show increased oxidation of the
CPH probe infused into old mice at rest compared with adult mice.
Fig. 2B shows representative images of EPR spectra from the
nerves of old mice during and following contractile activity. In the
2 h period following contractile activity, adult mice showed no
further increase in oxidation of the CPH probe, but a signiﬁcant
increase was observed post-contractions in old mice. By 24 h post-
contractions oxidation in nerves of old mice had returned to pre-
contraction levels. No changes were seen following contractile
activity in the sciatic nerves of adult mice. The protein carbonyl
content of sciatic nerves was analysed by western blotting as a
marker of oxidative damage, but no signiﬁcant differences were
seen between the intensity of bands obtained from nerves of adult
and old mice at rest (Fig. 2C).
Global proteomic analysis of the nerves showed signiﬁcant
changes in abundance of a number of proteins. These are shown as
a “volcano plot” in Fig. 3A with selected protein identiﬁed with a
score 10log P420 (equivalent to Po0.01). A total of 862 pro-
teins were identiﬁed from adult and old sciatic nerves and the full
list is included in Supplementary File 2. Proteins that were sig-
niﬁcantly decreased in content in the nerves from old mice were
primarily structural proteins reﬂecting the extensive changes in
axonal structure seen in Fig. 1 (highlighted in blue), a number of
proteins showing an increased content have previously been
identiﬁed as up regulated in brain during aging and in neurode-
generative diseases [34], including Apolipoproteins D and E, Ca-
thepsin B and D and Galectin 3 (highlighted in orange). There was
also an increase in the content of proteins known to function in
regulation of reactive oxygen species and protein thiol homo-
eostasis (highlighted in red). In order to investigate the
Fig. 1. Example semi-thin sections from transverse sections of the sciatic nerves of adult (A) and old (B) mice (n¼7). Myelin sheaths are indicated by arrows and axons by
arrowheads.
Table 1
Quantiﬁcation of changes in sciatic nerve structure from old and adult mice.
Adult Old
Axon diameter (lm) 7.970.11 6.9970.10*
Axon number 131721 113717*
Myelin area (lm2) 36.2470.78 25.5370.70*
Fig. 2. (A) Intensity of EPR signals derived from sciatic nerves of adult (open bars) and o
mice at rest (Control), over 2 h following a 15 min period of isometric contractions (Imm
with values from adult mice at the same time point; ΔPo0.05 compared with values in
nerve of old mice prior (green line) immediately after a period of isometric contractions
content of sciatic nerve from old and adult mice. (For interpretation of the references to
(For interpretation of the references to colour in this ﬁgure legend, the reader is referre
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volved in the regulation of redox homoeostasis that had an in-
creased content in the nerves from old mice Prdx5 (P
value¼0.0003) and Prdx6 (P value¼0.007) were also examined by
western blotting (Fig. 3B). This showed a trend towards an in-
creased content with ageing for both proteins, but did not reach
signiﬁcance.ld (ﬁlled bars) mice (n¼7). The CPH probe was infused via the tail vein over 2 h to
ediate) or over the period 2224 h post-contractions (24 h). * Po0.005 compared
same group at the previous time point. (B) Representative EPR signals from sciatic
(red line) and 24 h later (black line). (C) Western blot analysis of protein carbonyl
colour in this ﬁgure legend, the reader is referred to the web version of this article.)
d to the web version of this article.)
Fig. 3. (A) Volcano plot showing changes in protein contents between sciatic nerves from old compared with adult mice detected by PEAKS label-free quantiﬁcation
software. Key structural proteins that are down-regulated in old mice are shown in blue and proteins involved in redox regulation that are up-regulated are shown in red.
Proteins associated with neurodegenerative diseases and up-regulated with age are highlighted in orange. Proteins highlighted are ACTS (Actin alpha), AK1A1 (Alcohol
dehydrogenase [NADPþ], APOD (Apolipoprotein D), APOE (Apolipoprotein E), CATB (Cathepsin B), CATD (Cathepsin D), CLUS (Clusterin) GPX1 (Glutathione peroxidase 1),
GRP78 (78 kDa glucose-regulated protein), LEG3 (Galectin-3), MLRS (Myosin regulated light chain 2), MYH4 (Myosin-4), MYL1 (Myosin light chain 1), MYL3 (Myosin light
chain 3), PDIA6 (Protein disulphide isomerase A6), PRDX1 (Peroxiredoxin 1), PRDX5 (Peroxiredoxin 5), PRDX6 (Peroxiredoxin 6), TPM1 (Tropomyosin alpha-1 chain), TPM2
(Tropomyosin beta chain), VTDB (Vitamin D-binding protein) and ZO3 (Tight junction protein ZO-3). (B) Western blot analysis of the peroxiredoxin 5 and 6 contents of sciatic
nerves from adult and old mice (7 SEM). (C) The proportion of Cys47 of peroxiredoxin 6 in the reversibly oxidised, reduced and sulﬁnic forms from adult and old mice.
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contained cysteines in the reduced (NEM labelled) and reversibly
oxidised (D5-NEM labelled) forms. Redox-sensitive cysteines were
identiﬁed by mass spectrometry and the changes in the relative
proportion of those cysteines found in the reduced or oxidised
form in adult and old mice can be estimated. A number of these
cysteines showed substantially greater oxidation in the samples
from old compared with adult mice including Cys114 of Annexin
A6, Cys254 of Creatine kinase b, Cys47 of Prdx6 and Cys49 of
pyruvate kinase M1/M2. This relative oxidation was not universal
and the reverse changes (i.e. greater proportion of the reduced
form) were also seen in key proteins including Cys163 of lactate
dehydrogenase, Cys85 of Cytochrome bc1 complex subunit 1,
Cys336 of Nucleolar GTP binding protein 1 and Cys260 of the
Serine protease inhibitor A3K. The majority of the redox sensitive
cysteines identiﬁed are in structural or cytoskeletal regulatory
proteins including Actin alpha (Cys287) and cytoplasmic (Cys257),
Galectin-1 (Cys61), Gelsolin (Cys280 & 670), Myosin regulatory
light chain (Cys128), Neuroﬁlament light (Cys323) and heavy
chains (Cys225, 246, 263 & 409), Periaxin (Cys86) Periperin(Cys328), Plastin (Cys336), Synaptic vesicle membrane protein
(Cys99), Tubulin (Cys315/316, 376 & 303) and Vimentin (Cys328).
It is also interesting to note that a number of these structural
proteins also changed in abundance between sciatic nerves of
adult and old mice (highlighted in Table 2).
The 1-Cys peroxiredoxin, Prdx6, was identiﬁed as containing a
redox sensitive cysteine residue (Cys47). Prdx6 has both perox-
idase and phospholipase activities, the peroxidase activity of this
protein relies on the redox state of Cys47, which was examined in
greater detail as shown in Fig. 3C, Cys47 was identiﬁed in the re-
duced, reversibly oxidised and the sulﬁnic (SO2H) forms. Sciatic
nerves from old mice showed a 10% increase in the reversibly
oxidised form of Cys47 compared with those from adult mice.
Other regulatory proteins identiﬁed as containing redox sensitive
cysteines include Rab GDP dissociation inhibitor (Cys202) and Rho
GDP dissociation inhibitor (Cys79), that regulate both Rab and Rho
proteins respectively, involved in membrane and intracellular ve-
sicular trafﬁcking and are highly expressed in the spinal cord
[35,36].
Table 2
Redox sensitive targets with relative quantiﬁcation of oxidative state of susceptible Cys residues and relative protein abundance, proteins in bold also change in abundance.
Accession Protein Adult Vs. aged (-)10log P Redox Cys Adult Red/Ox Aged Red/Ox
P68254 14-3-3 protein theta (Ywaq) 1.00:1.59 21.52 Cys134 4.38 4.12
P63101 14-3-3 protein zeta/delta (Ywhaz) 1.00:1.34 11.31 Cys25 3.64 3.16
Cys94 4.81 4.41
P68134 Actin, alpha skeletal muscle (Acta1) 1.00:0.4 59.6 Cys287 7.53 3.90
P60710 Actin, cytoplasmic 1 (Actb) 1.00:1.69 10.82 Cys257 12.96 10.24
P17183/2 Gamma-enolase (Eno1)/Alpha-enolase (Eno1) 1.00:1.41 8.84 Cys399 3.09 2.58
P07724 Albumin serum (Alb) 1.00:1.78 45.23 Cys58 0.82 1.34
Cys77 0.02 0.03
Cys289 0.02 0.02
Cys500/501 0.03 0.01
P14824 Annexin A6 (Anxa6) 1.00:1.14 2.99 Cys114 9.54 8.44
Q61878 Bone marrow proteoglycan (Prg2) 0.00:0.100 36.64 Cys198/202 3.15 2.44
P10605 Cathepsin B (Ctsb) 1.00:8.49 30.49 Cys105/108 0.15 0.13
Q04447 Creatine kinase B-type (Ckb) 1.00:0.68 0.06 Cys254 1.25 1.16
Q9CZ13 Cytochrome b-c1 complex subunit 1, mitochondrial (Uqcrc1) 1.00:0.46 16.83 Cys380 1.57 1.99
Q80UW2 F-box only protein 2 (Fbxo2) 1.00:0.94 1.88 Cys75 6.42 5.96
Cys79 0.10 0.11
P16045 Galectin-1 (Lgals1) 1.00:1.97 14.51 Cys61 4.14 3.28
Q6PAC1 Gelsolin, isoform CRA_c (Gsn) 1.00:1.38 17.23 Cys280 7.92 7.28
Cys670 130.47 135.52
P16858 Glyceraldehyde-3-phosphate dehydrogenase (Gapdh) 1.00:0.96 1.23 Cys245 6.02 5.46
P62874 Guanine nucleotide-binding protein subunit beta-1 (Gnb1) 1.00:0.89 2.45 Cys148/149 22.75 11.48
P06151 L-lactate dehydrogenase A chain (Ldha) 1.00:1.54 11.12 Cys163 2.13 1.90
P16125 L-lactate dehydrogenase B chain (Ldhb) 1.00:1.65 9.36 Cys163 2.13 1.90
P97457 Myosin regulatory light chain 2, skeletal muscle isoform (Mylpf) 1.00:0.32 31.83 Cys128 2.93 1.79
F7A3A1 Neuroﬁlament heavy polypeptide (Nefh) 1.00:0.81 9.84 Cys225 4.26 4.16
Cys246 1.91 1.94
Cys263 9.44 7.21
Cys409 6.11 6.98
P08551 Neuroﬁlament light polypeptide (Neﬂ) 1.00:0.80 10.71 Cys323 5.34 2.88
Q99ME9 Nucleolar GTP-binding protein 1 (Gtpbp4) 1.00:1.67 12.49 Cys336 13.15 15.35
E9QQ57 Periaxin (Prx) 1.00:1.13 5.08 Cys86 3.56 4.06
G5E846 Peripherin (Prph) 1.00:0.74 13.04 Cys148 2.85 2.39
Cys328 3.45 2.77
P17742 Peptidyl-prolyl cis-trans isomerase A (Ppia) 1.00:1.11 2.26 Cys62 1.85 1.81
O08709 Peroxiredoxin 6 (Prdx6 ) 1.00:1.54 21.46 Cys47 1.36 1.05
Q61233 Plastin 2 (Lcp1) 1.00:3.20 48.17 Cys336 0.22 0.42
P52480 Pyruvate kinase isozymes M1/M2 (Pkm2) 1.00:0.56 28.18 Cys49 4.20 3.90
P50396 Rab GDP dissociation inhibitor alpha (Gdi1 ) 1.00:1.28 7.7 Cys202 4.40 3.80
Q99PT1 Rho GDP-dissociation inhibitor 1 (Arhgdia) 1.00:1.72 25.46 Cys79 10.32 12.91
P07759 Serine protease inhibitor A3K (Serpina3k) 1.00:1.21 2.05 Cys260 4.13 5.47
P16546 Spectrin alpha chain brain (Sptan1) 1.00:0.88 1.24 Cys956 4.20 3.90
Cys1454 3.56 2.90
Q8VDN2 Sodium/potassium-transporting ATPase subunit alpha1 (Atp1a1) 1.00:0.96 1.21 Cys249 3.52 3.37
Q62465 Synaptic vesicle membrane protein VAT1 homologue (Vat1) 1.00:2.31 32.94 Cys99 0.84 0.98
H7BXC3 Triosephosphate isomerase (Tpi1) 1.00:1.49 8.47 Cys136 3.77 2.72
P68369/8 Tubulin alpha1 A chain (Tuba1a)/Tubulin alpha4 A chain (Tuba4a) 1.00:0.78 7.26 Cys315/316 3.85 2.02
Cys376 1.16 1.05
Cys303 5.50 5.40
Q9R0P9 Ubiquitin carboxyl-terminal hydrolase isozyme L1 (Uchl1) 1.00:1.14 2.75 Cys152 6.00 5.78
P20152 Vimentin OS (Vim) 1.00:1.67 35.87 Cys328 3.91 3.59
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Substantial loss of neuromuscular structure and function has
been shown to occur during ageing that presents as loss and
atrophy of muscle ﬁbres, a decline in the integrity of NMJ and loss
of motor units [4,10]. Muscles that are innervated by the sciatic
nerve in mice are substantially affected by aging with a loss of
numbers of ﬁbres and atrophy and weakness of the remaining
ﬁbres [19]. This is associated with disruption of some NMJ and the
substantial degenerative changes in axons seen in Fig. 1, but the
relationship between the nerve and muscle changes is not un-
derstood in detail nor is whether the changes in both tissues occur
independently or whether degeneration of one tissue leads to the
other (e.g. functional denervation leads to atrophy of muscle ﬁ-
bres). At the ages studied here, skeletal muscles of old mice con-
tain increased amounts of oxidative damage including increased
protein carbonyls [29,37], but no evidence for this was found inthe sciatic nerve despite the substantial disruption of nerve
structure that was observed. In order to investigate whether more
subtle changes in oxidation occurred in the nerve of old mice, we
therefore used both EPR and redox proteomics approaches.
Infusion of the spin probe via the tail vein and subsequent
analysis of the EPR signal from excised tissues has previously been
used to demonstrate increased activity of reactive oxygen species
in old rodents [28]. The CPH spin probe used reacts predominantly
with superoxide or peroxynitrite species and is partially cell
permeable. The signal obtained is therefore assumed to arise from
both intracellular and extracellular oxidation [38]. CPH oxidation
was found to be increased in the sciatic nerves of old mice at rest
compared with nerves from adult mice indicating an increased
activity of superoxide and/or peroxynitrite. Following 15 min of
stimulation of muscle contractions, the CPH oxidation further in-
creased in sciatic nerve from old mice, but no signiﬁcant effect on
CPH oxidation in adult mice was seen (Fig. 2A and B). The spectra
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trite reaction with CPH, but the current data do not permit an
evaluation of the likely source of the superoxide or peroxynitrite
activity detected at rest or the increase that occurred only in nerve
of old mice with activation. It seems unlikely that activation of the
nerve would directly stimulate intrinsic ROS generation from the
tissue only in old mice and we speculate that the increase is likely
to be related to increased pro-inﬂammatory response in old mice
during extensive activity as suggested by [39]. As previously sta-
ted, the CPH probe can react with ROS in both intracellular and
extracellular sources and hence the increase is compatible with an
increase in circulating inﬂammatory mediators.
Proteomic analyses revealed a number of changes in protein
content in nerves from old mice compared with those from adult
mice including a substantial number of proteins that either in-
creased or decreased in abundance (Fig. 3A). The proteins showing
a signiﬁcant decrease in content were predominantly structural
proteins and a number of redox sensitive cysteine residues were
identiﬁed in those proteins. Proteins that had a signiﬁcant in-
creased content included a number of lipid binding proteins and
proteases that have been identiﬁed to be increased in mammalian
brains during aging and neurodegenerative disesases including the
proteases Cathepsin B and D, and also the lipid binding proteins,
Apolipoprotein D and E, [40–42]. Cathepsin D knockout mice die
from a neurodegenerative liposomal storage disease [43] and it
has also been reported that the lipid binding protein Apo E is a
substrate of the cysteine protease Cathepsin D [34,44]. These ly-
sosomal proteases have also been implicated in the degradation of
α-Synuclein linked to the neuropathology of Parkinson’s disease
[45]. The glycoprotein Galectin-3 was also up regulated, this pro-
tein induces ﬁbrosis in animal models and has been proposed as a
biomarker for prognosis and management in heart failure [46,47].
Interestingly a number of proteins involved in regulation of cel-
lular redox processes (i.e. Prdx5, Prdx6, Prdx1 protein disulphide
isomerase and glutathione peroxidase 1, see Supplementary ﬁle 2)
were also detected as up regulated by the proteomic approach. An
increase in the content of such “antioxidant” enzymes is widely
recognised to occur in response to increased activity of ROS in
muscle tissue [19,48] and in nerves following exposure to neuro-
trophic factors [49] and we speculate that these changes reﬂect an
adaptation in old mice to increased ROS activity in the nerve that
we observed with the EPR experiments (Fig. 2).
We attempted to conﬁrm the proteomic changes in the per-
oxiredoxins using western blotting, but although the content in
tissues from old mice showed a trend towards an increase in
abundance, the increase was not statistically signiﬁcant (Fig. 3).
The proteomic approach used also provided information on the
redox status of speciﬁc cysteine groups in proteins [50] and a list
of the proteins with redox-active cysteines detected in the nerves
is shown in Table 2. This table also shows the relative proportion
of the speciﬁc cysteine group present in the reduced or reversibly
oxidised form in nerve tissue from old compared with adult mice.
Multiple proteins involved in metabolism, cytoskeleton, calcium
sensitivity and antioxidant enzymes contain redox sensitive cy-
steine residues, whose redox state dictate activity and function
and a number of the proteins identiﬁed showed an increased
proportion of the cysteine in the oxidised form (e.g. Cys114 of
Annexin A6, Cys254 of Creatine kinase b, Cys263 of Neuroﬁlament
heavy polypeptide, Cys47 of Prdx6 and Cys49 of Pyruvate kinase
M1/M2). However, this pattern was not universally found and
some cysteines showed a greater proportion in the reduced form.
Structures or molecules in close proximity to the site of ROS
generation are most likely to undergo redox modiﬁcations and
redox modiﬁcations in key metabolic processes can alter a wide
variety of downstream protein targets, inﬂuencing a variety of key
regulators of distinct post translational modiﬁcations such asphosphorylation, acetylation and ubiquitination. Transient oxida-
tion and reduction of key cysteines in regulatory proteins is a key
aspect of redox signalling processes and can effect activity [50,51]
which may be especially important when dealing with proteins
with more than one function and where changes in the redox state
of a particular cysteine residue may result in the gain or loss of one
of these activities. The variable changes in oxidation status seen in
redox-active cysteines between nerves from old and adult mice is
likely to reﬂect modiﬁed signalling rather than any indication of an
overt, age-related increase in oxidation in this tissue.
Prdx6 is a key protein involved in regulation of reactive oxygen
species and in redox signalling. It is a 1-cysteine peroxiredoxin in
comparison to the 2-cysteine peroxiredoxins (Prdx’s 1-5), that
require a structurally close resolving cysteine and the subsequent
reduction of the disulﬁde bond generated by thioredoxin for
completion of their catalytic cycles. The phosphorylation of T177 of
human Prdx6 also confers a second activity on the protein, as a
Ca2þ-independent Phospholipase A2 through which it has been
reported to activate plasma membrane NAD(P)H oxidase (NOX2)
[52]. Prdx6 has been described as playing a role in the repair of
oxidised phospholipids in cell membranes [53] and if the phos-
pholipase activity is inhibited, it has been reported to help prevent
lung damage after hypoxia [54]. The yeast orthologue of this 1-Cys
peroxiredoxin, Prx1p, can be resolved and maintained in its active
peroxiredoxin form by physiological concentrations of reduced
glutathione indicating a robust recycling mechanism [55]. There-
fore, although the current analysis of the redox status of the cat-
alytic cysteine (Cys47) indicated no increased formation of the
irreversibly oxidised sulﬁnic form, an increased proportion was
present in the reversibly oxidised form (Fig. 3C), suggesting a
sustained mild reversible oxidation. Such changes may have
downstream redox signalling effects, for example, a loss in per-
oxidase activity but gain in phospholipase and NOX2 activities.
Thus in conclusion, the sciatic nerves from old mice are
structurally small but do not show an age-related gross increase in
oxidative damage in a similar manner to the muscles they in-
nervate. However, EPR studies indicated an increase in the activity
of superoxide and/or peroxynitrite occurs in the nerve of old mice
at rest that was further exacerbated by electrical stimulation of the
nerve to activate muscle contractions. Proteomic analyses in-
dicated that speciﬁc redox sensitive proteins are increased in
content in the nerves of old mice that may reﬂect an adaptation to
regulate the increased superoxide/peroxynitrite and maintain re-
dox homoeostasis. Targeted analysis of the redox active cysteines
of proteins show some increase in reversible oxidation in nerves of
old mice, but this was not universal across all redox-active cy-
steines. Subtle changes in the oxidative state of key redox regu-
lated proteins in the nerves of old mice would be compatible with
a reduced capacity to participate in redox signalling in response to
stimulation.Acknowledgements
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